The popularity of Sildenafil initially fueled a boom for pharma, nevertheless recent shifts present a complicated picture for shareholders. Off-patent competitors are eating into revenue, and continued litigation add https://cecilypctp033340.bloggazza.com/39902882/sildenafil-and-the-pharmaceutical-industry-a-risky-bet